FLAMINGO: still in the pink?

Affiliations

¹ Chelsea and Westminster NHS Foundation Trust, London UK. Electronic address: t.barber@nhs.net.
² Chelsea and Westminster NHS Foundation Trust, London UK.

Comment

Tristan J Barber et al. Lancet HIV. 2015 Apr.

. 2015 Apr;2(4):e116-7.

doi: 10.1016/S2352-3018(15)00037-5. Epub 2015 Mar 10.

¹ Chelsea and Westminster NHS Foundation Trust, London UK. Electronic address: t.barber@nhs.net.
² Chelsea and Westminster NHS Foundation Trust, London UK.

No abstract available

Comment on

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study.
Molina JM, Clotet B, van Lunzen J, Lazzarin A, Cavassini M, Henry K, Kulagin V, Givens N, de Oliveira CF, Brennan C; FLAMINGO study team. Molina JM, et al. Lancet HIV. 2015 Apr;2(4):e127-36. doi: 10.1016/S2352-3018(15)00027-2. Epub 2015 Mar 10. Lancet HIV. 2015. PMID: 26424673 Clinical Trial.